QUANTELLIX Trademark

Trademark Overview

On Wednesday, July 16, 2014, a trademark application was filed for QUANTELLIX with the United States Patent and Trademark Office. The USPTO has given the QUANTELLIX trademark a serial number of 86339040. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 26, 2018. This trademark is owned by H. Lundbeck A/S. The QUANTELLIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of disorders and diseases in, generated by or acting on the central nervous system; sanitary preparations for medical purposes; vaccines; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes
quantellix

General Information

Serial Number86339040
Word MarkQUANTELLIX
Filing DateWednesday, July 16, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 26, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 25, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of disorders and diseases in, generated by or acting on the central nervous system; sanitary preparations for medical purposes; vaccines; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 22, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address2500 Valby
DK
Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address2500 Valby
DK

Trademark Events

Event DateEvent Description
Monday, February 26, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 26, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 5, 2017EXTENSION 5 GRANTED
Tuesday, July 18, 2017EXTENSION 5 FILED
Friday, August 4, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 18, 2017TEAS EXTENSION RECEIVED
Tuesday, July 18, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 28, 2016EXTENSION 4 GRANTED
Wednesday, December 28, 2016EXTENSION 4 FILED
Wednesday, December 28, 2016TEAS EXTENSION RECEIVED
Tuesday, July 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 2, 2016EXTENSION 3 GRANTED
Thursday, June 2, 2016EXTENSION 3 FILED
Thursday, June 2, 2016TEAS EXTENSION RECEIVED
Friday, February 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 4, 2016EXTENSION 2 GRANTED
Monday, December 28, 2015EXTENSION 2 FILED
Monday, December 28, 2015TEAS EXTENSION RECEIVED
Saturday, June 20, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 19, 2015EXTENSION 1 GRANTED
Tuesday, May 19, 2015EXTENSION 1 FILED
Wednesday, June 17, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 19, 2015TEAS EXTENSION RECEIVED
Monday, April 20, 2015ASSIGNED TO EXAMINER
Tuesday, January 20, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 25, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 25, 2014PUBLISHED FOR OPPOSITION
Wednesday, November 5, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 20, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 14, 2014ASSIGNED TO LIE
Friday, September 26, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 26, 2014EXAMINER'S AMENDMENT ENTERED
Friday, September 26, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 26, 2014EXAMINERS AMENDMENT E-MAILED
Friday, September 26, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 24, 2014ASSIGNED TO EXAMINER
Tuesday, July 22, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 19, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

quantellix preparations substances disorder pharmaceutical disease system disorders nervous central treatment